Skip to main content
. 2016 Jun 3;6:27211. doi: 10.1038/srep27211

Table 4. Reactivity of HA subtype-specific RT-qPCR assays used in RITA with the validation panel of 404 viral isolates.

RT-qPCR H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16
IAV-H1-Mix 3 51 -
IAV–H1–Mix 27 53 37* 3*
IAV–H2–Mix 4 18
IAV–H2–Mix 10 18 1* - -
IAV–H3–Mix 3 35
IAV–H3–Mix 14 40
IAV–H4–Mix 15 17
IAV-H5-Mix 1 87
IAV–H5a–Mix 1 88
IAV-H6-Mix 8 61
IAV-H7-CODA 1* 33 1* 1*
IAV–H7-Mix 2 35 6* ––
IAV-H7-Mix 2.2 35
IAV-H8-Mix 1 3
IAV-H9-Mix 2 31
IAV-H10-Mix 5 30# 29
IAV-H10-Mix 9 30 29
IAV-H11-Mix 1 11
IAV-H12-Mix 3 1
IAV-H13-Mix 2 10
IAV-H16-Mix 6 4
total 54 18 40 17 88 61 35 3 31 29 11 1 10 1 1 4

*Δ Cq between pan assay and false positive reactivity ≥10 and Δ Cq between specific assay and false positive reactivity ≥8.

#Δ Cq between pan assay and false positive reactivity ≥3 and Δ Cq between specific assay and false positive reactivity ≥3.

Δ Cq between pan assay and false positive reactivity ≥5; and Δ Cq between specific assay and false positive reactivity ≥4.

HHS Vulnerability Disclosure